Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial

Date Issued
2017
Author(s)
Einsele, Hermann
Engelhardt, Monika
Tapprich, Christoph
Müller, Jürgen
Liebisch, Peter
Langer, Christian
Kropff, Martin
Mügge, Lars O.
Wolf, Hans-Heinrich
Metzner, Bernd
Hart, Christina
Gramatzki, Martin
Hertenstein, Bernd
Pfreundschuh, Michael
Rösler, Wolf
Fischer, Thomas
Maschmeyer, Georg
Kanz, Lothar
Hess, Georg
Jäger, Elke
Bentz, Martin
Dürk, Heinz A.
Salwender, Hans
Hebart, Holger
Straka, Christian
Knop, Stefan
DOI
10.1111/bjh.14920